Treatment Comparison

Mitral Valve Repair vs Replacement: Which Surgery Is Better?.

Sandeep M. Patel, MD
Sandeep M. Patel, MD
13 min read · Updated 2026-03-07

For patients with severe mitral regurgitation requiring surgery, the choice between mitral valve repair and mitral valve replacement is one of the most consequential decisions in cardiac surgery. When feasible, repair is strongly preferred — it preserves native valve tissue, maintains left ventricular geometry, avoids prosthesis-related complications, and is associated with better long-term survival. The 2020 ACC/AHA Guidelines give mitral repair a Class I recommendation over replacement for degenerative mitral regurgitation. However, not all mitral valves can be repaired. The feasibility and durability of repair depend on the etiology (degenerative vs functional vs rheumatic), the specific leaflet pathology, annular calcification, and critically, the experience of the surgeon. Reference centers report repair rates exceeding 95% for degenerative disease, while community hospitals may achieve only 50-60%. Understanding when repair is possible, when replacement is necessary, and what constitutes an adequate repair requires expert surgical judgment — making this one of the most important areas for a second opinion in cardiac surgery.

Head-to-head comparison.

Option A

Mitral Repair

Mitral Valve Repair

Mitral valve repair reconstructs the patient's own valve using a combination of techniques: annuloplasty ring placement, leaflet resection, chordal transfer or replacement with Gore-Tex neochordae, edge-to-edge repair (Alfieri stitch), and commissuroplasty. The goal is to restore normal leaflet coaptation and eliminate regurgitation while preserving native tissue and subvalvular apparatus.

Advantages
Superior long-term survival compared to replacement
Preserves native valve tissue and subvalvular apparatus
No need for long-term anticoagulation in most cases
Lower operative mortality (1-2% at reference centers)
Maintains left ventricular geometry and function
Lower risk of endocarditis compared to prosthetic valves
Limitations
Not feasible for all valve pathologies (extensive calcification, rheumatic disease)
Outcomes highly dependent on surgeon expertise and volume
Risk of repair failure requiring reoperation (5-10% at 10 years)
More technically demanding and time-consuming than replacement
Functional MR repair has higher recurrence rates than degenerative MR repair
Best For
Degenerative mitral regurgitation (prolapse, flail leaflet)
Patients with isolated posterior leaflet disease
Younger patients seeking to avoid prosthesis-related complications
Patients at experienced mitral repair centers (>95% repair rate)
0.5-2%
Operative Mortality
90-95%
Freedom from Reoperation (10yr)
Not required
Anticoagulation
Option B

Mitral Replacement

Mitral Valve Replacement

Mitral valve replacement removes the diseased valve leaflets (ideally preserving the subvalvular apparatus) and implants a mechanical or bioprosthetic prosthesis. It is the definitive option when repair is not feasible or durable. The choice between mechanical and bioprosthetic replacement follows the same considerations as aortic valve prosthesis selection — durability vs anticoagulation burden.

Advantages
Definitive solution regardless of valve pathology
Predictable and reproducible outcomes across surgeon experience levels
Appropriate for heavily calcified or rheumatic valves
Eliminates regurgitation completely
Mechanical option provides lifetime durability
Limitations
Higher operative mortality than repair (3-6%)
Requires anticoagulation if mechanical prosthesis used
Loss of native valve tissue and potential LV geometry disruption
Bioprosthetic valves have limited durability in the mitral position (faster SVD)
Higher long-term mortality compared to successful repair
Higher risk of prosthetic valve endocarditis
Best For
Rheumatic mitral valve disease with extensive fibrosis/calcification
Failed prior mitral repair
Mitral stenosis (MS) that cannot be treated with commissurotomy
Extensive annular calcification precluding durable repair
3-6%
Operative Mortality
10-15 years
Prosthesis Durability (Bioprosthetic)
Required if mechanical
Anticoagulation
Clinical Evidence

Key clinical trials.

2016
Goldstein et al. (CTSN)
Severe ischemic MR: repair vs replacement showed no survival difference at 2 years. However, repair had a significantly higher recurrence rate of moderate-severe MR (58.8% vs 3.8%), leading many to favor replacement for ischemic MR.
2014
Acker et al. (CTSN)
Moderate ischemic MR during CABG: adding mitral repair to CABG reduced MR grade but did not improve survival or LV remodeling at 2 years vs CABG alone.
2019
David et al. (Toronto)
Long-term outcomes of mitral repair for degenerative disease: freedom from reoperation was 96% at 20 years. Repair durability was excellent when performed by experienced surgeons.
2015
Suri et al. (Mayo Clinic)
Mitral repair associated with superior long-term survival compared to replacement for degenerative MR, with the benefit persisting at 20 years. Surgeon volume was a significant determinant of repair success.
Practice Guidelines

What the guidelines say.

The 2020 ACC/AHA Guidelines give mitral valve repair a Class I recommendation over replacement for patients with chronic severe primary (degenerative) MR when a durable repair can be achieved. Referral to an experienced surgical center with demonstrated high repair rates (>95%) and low mortality (<1%) is recommended when repair is expected (Class I). For secondary (functional/ischemic) MR, the guidelines note repair has higher recurrence rates and replacement may be preferred.

Heart Team Approach

Why the Heart Team matters.

The repair vs replacement decision is perhaps the most surgeon-dependent decision in cardiac surgery. Surgeon experience and institutional repair rates are the strongest predictors of repair feasibility and durability. A cardiologist provides detailed echocardiographic assessment of valve anatomy (Barlow's, fibroelastic deficiency, commissural disease), while the surgeon evaluates repairability. WhiteGloveMD provides a second opinion on whether repair is feasible, and whether the patient should seek a referral to a high-volume mitral repair center.

The Bottom Line

Mitral valve repair is strongly preferred over replacement for degenerative mitral regurgitation — it offers better survival, no anticoagulation, and preserved ventricular function. However, repair feasibility depends on valve pathology and surgeon expertise. Patients should ask about their surgeon's personal repair rate and consider referral to a reference center. For functional/ischemic MR, the repair vs replacement calculus is different, with replacement sometimes preferred due to high repair recurrence rates.

Frequently asked questions.

How do I know if my mitral valve can be repaired?

Degenerative mitral valve disease (prolapse, flail leaflet) is highly repairable, with reference centers achieving >95% repair rates. Rheumatic, heavily calcified, or complex bileaflet disease is more challenging. A detailed echocardiogram and evaluation by an experienced mitral surgeon are essential.

What is a surgeon's repair rate and why does it matter?

Repair rate is the percentage of mitral surgeries where the surgeon performs a repair rather than replacement. Centers with >95% repair rates have better outcomes. National repair rates remain around 65%, meaning many patients receive replacements that could have been repairs at an experienced center.

What if my repair fails?

Early repair failure (operative) may require conversion to replacement during the same surgery. Late repair failure (years later) can be addressed with redo repair, replacement, or in some cases MitraClip. Overall freedom from reoperation after degenerative repair is 90-96% at 10-20 years at experienced centers.

Is mitral valve repair always better than replacement?

For degenerative MR, repair is clearly preferred when durable repair is achievable. For ischemic/functional MR, the CTSN trial showed higher MR recurrence after repair (58.8% vs 3.8%), so replacement may be preferred. The etiology of MR is the key distinction.

Stay informed.
Expert cardiac surgery insights from the WhiteGloveMD Heart Team, delivered to your inbox.
No spam. Unsubscribe anytime. HIPAA-compliant.

Not sure which option is right for you?

Our Heart Team evaluates your specific anatomy, risk factors, and goals to recommend the best approach. 48-hour turnaround.

Get Your Second Opinion Risk Calculator
Related Conditions
Mitral RegurgitationMitral Valve Prolapse
Related Comparisons
Mitraclip Vs SurgeryMechanical Vs Bioprosthetic